3 Biotech Stocks That Soared: Are They Buys? Sat, 18 Nov 2017 22:47:00 +0000 Could Nektar Therapeutics, Wave Life Sciences, and Savara go even higher after huge gains this past week?
Wave Life Sciences reports 3Q loss Thu, 09 Nov 2017 13:06:02 +0000 The Singapore-based company said it had a loss of 94 cents per share. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for ...
Wave Life Sciences Ltd. breached its 50 day moving average in a Bearish Manner : WVE-US : November 8, 2017 Wed, 08 Nov 2017 15:51:55 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Wave Life Sciences Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
(Read more...)
Wave Life Sciences Initiates Clinical Trial for Lead Program in Duchenne Muscular Dystrophy (DMD) Mon, 06 Nov 2017 12:00:00 +0000 Wave Life Sciences Ltd. , a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced the initiation of a global Phase 1 clinical trial for WVE-210201 in Duchenne muscular dystrophy patients amenable to exon 51 skipping.
Wave Life Sciences Ltd. – Value Analysis (NASDAQ:WVE) : October 30, 2017 Mon, 30 Oct 2017 16:52:31 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Wave Life Sciences Ltd. a score of 20. Our analysis is based on comparing Wave Life Sciences Ltd. with the following peers – NextEra Energy, Inc., Exelon Corporation and E.ON SE Sponsored ADR (NEE-US, EXC-US and EONGY-US). Investment Outlook Wave Life Sciences Ltd. has a fundamental score ... Read more
(Read more...)
Wave Life Sciences Unveils New Manufacturing Facility in Lexington, MA Thu, 26 Oct 2017 20:00:00 +0000 Wave Life Sciences Ltd. , a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced the public opening of its new 90,000 square foot state-of-the-art manufacturing facility and office space in Lexington, Massachusetts.
ETFs with exposure to Wave Life Sciences Ltd. : October 23, 2017 Mon, 23 Oct 2017 15:17:14 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Wave Life Sciences Ltd. Here are 5 ETFs with the largest exposure to WVE-US. Comparing the performance and risk of Wave Life Sciences Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
(Read more...)
Wave Life Sciences to Present at the Jefferies Gene Technology Investor Summit Thu, 12 Oct 2017 11:00:00 +0000 Wave Life Sciences Ltd. , a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno, M.D., MBA, President and Chief Executive Officer, will present at the Jefferies Gene Technology Investor Summit on Thursday, October 12, 2017 at 8:20 A.M.
ETFs with exposure to Wave Life Sciences Ltd. : September 1, 2017 Fri, 01 Sep 2017 02:11:51 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Wave Life Sciences Ltd. Here are 5 ETFs with the largest exposure to WVE-US. Comparing the performance and risk of Wave Life Sciences Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 2.11 (median winner: 1.53)
Instit. Ownership: 74% (median winner: 63%)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.